Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Melarange

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Agents and Actions. Supplements|January 1, 1991
Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenacR Melarange, C Gentry, C O'Connell, et al.
Digestive Diseases and Sciences|March 1, 1994
Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolacR Melarange, C Gentry, M Durie, et al.
Digestive Diseases and Sciences|December 1, 1995
Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the ratR Melarange, C Gentry, C D Toseland, et al.
European Journal of Rheumatology and Inflammation|January 1, 1994
Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolacR Melarange, C Gentry, P R Blower, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1992
A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ-free ratsR Melarange, G Moore, P R Blower, et al.
Digestive Diseases and Sciences|December 1, 1992
Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacinR Melarange, C Gentry, C O'Connell, et al.
Agents and Actions|January 1, 1992
Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacinR Melarange, C Gentry, C O'Connell, et al.
British Journal of Pharmacology|May 6, 2008
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1C J Langmead, N E Austin, C L Branch, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Agents and Actions. Supplements|January 1, 1991
Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenacR Melarange, C Gentry, C O'Connell, et al.
Digestive Diseases and Sciences|March 1, 1994
Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolacR Melarange, C Gentry, M Durie, et al.
Digestive Diseases and Sciences|December 1, 1995
Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the ratR Melarange, C Gentry, C D Toseland, et al.
European Journal of Rheumatology and Inflammation|January 1, 1994
Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolacR Melarange, C Gentry, P R Blower, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1992
A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ-free ratsR Melarange, G Moore, P R Blower, et al.
Digestive Diseases and Sciences|December 1, 1992
Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacinR Melarange, C Gentry, C O'Connell, et al.
Agents and Actions|January 1, 1992
Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacinR Melarange, C Gentry, C O'Connell, et al.
British Journal of Pharmacology|May 6, 2008
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1C J Langmead, N E Austin, C L Branch, et al.
Pageof 2